Get Who You Want, Not Who They Have: Why Multitherapeutic Resources Aren't Always The Answer

iOver the Shoulder Shot of Senior Medical Scientist Working Stock-1050311748

Chief medical officers looking for outsourcing services on a study are often fed lines from large CROs on how they can provide individuals with multitherapeutic backgrounds. These industry giants are supposedly poised to handle a variety of highly specialized areas of study, but in reality, the benefit of a multitherapeutic background is exaggerated. Studies involving oncology, neurodegenerative diseases, orphan and rare disease, etc. are all uniquely challenging, and being effective in one area does not mean you can do them all. If we put the technical expertise aside for a moment -  anyone who has been in this industry long enough knows that quality work comes from people who share attributes of excellence, and an understanding and appreciation that the work they are doing involves a scientific experiment on a human. Studies are more likely to succeed when the people working on them have a true passion for the subject. So why do we roll the dice and let CROs tell us that their pool of “multitherapeutic” specialists are going to make our studies a success?

access the Product/Service!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Outsourced Pharma